355 related articles for article (PubMed ID: 32284755)
1. The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.
Yuan Y; Du Y; Wang L; Liu X
J Cancer; 2020; 11(12):3588-3595. PubMed ID: 32284755
[TBL] [Abstract][Full Text] [Related]
2. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.
He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y
Mol Cell Biochem; 2024 May; ():. PubMed ID: 38822192
[TBL] [Abstract][Full Text] [Related]
3. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.
Liu C; Ren Q; Deng J; Wang S; Ren L
Biomed J; 2023 Sep; ():100664. PubMed ID: 37774794
[TBL] [Abstract][Full Text] [Related]
4. m
Yue Z; Cao M; Hong A; Zhang Q; Zhang G; Jin Z; Zhao L; Wang Q; Fang F; Wang Y; Sun J
Front Oncol; 2021; 11():770325. PubMed ID: 35117988
[TBL] [Abstract][Full Text] [Related]
5. Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma.
Guo S; Chen F; Li L; Dou S; Li Q; Huang Y; Li Z; Liu W; Zhang G
J Adv Res; 2023 Aug; ():. PubMed ID: 37619934
[TBL] [Abstract][Full Text] [Related]
6. The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target.
Zhou X; Chai K; Zhu H; Luo C; Zou X; Zou J; Zhang G
BMC Cancer; 2024 Jan; 24(1):8. PubMed ID: 38166703
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanism of m6A Methylation Modification Genes
Chen B; Yuan C; Guo T; Liu J; Yang B; Lu Z
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569302
[TBL] [Abstract][Full Text] [Related]
8. Cancer mutations rewire the RNA methylation specificity of METTL3-METTL14.
Zhang C; Tunes L; Hsieh MH; Wang P; Kumar A; Khadgi BB; Yang Y; Doxtader KA; Herrell E; Koczy O; Setlem R; Zhang X; Evers B; Wang Y; Xing C; Zhu H; Nam Y
bioRxiv; 2023 Mar; ():. PubMed ID: 36993753
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Mettl3 ameliorates osteoblastic senescence by mitigating m6A modifications on Slc1a5 via Igf2bp2-dependent mechanisms.
Liu XW; Xu HW; Yi YY; Zhang SB; Chang SJ; Pan W; Wang SJ
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(7):167273. PubMed ID: 38844111
[TBL] [Abstract][Full Text] [Related]
10. SHMT2 regulates esophageal cancer cell progression and immune Escape by mediating m6A modification of c-myc.
Qiao Z; Li Y; Cheng Y; Li S; Liu S
Cell Biosci; 2023 Nov; 13(1):203. PubMed ID: 37932821
[TBL] [Abstract][Full Text] [Related]
11. IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism.
Pu J; Wang J; Qin Z; Wang A; Zhang Y; Wu X; Wu Y; Li W; Xu Z; Lu Y; Tang Q; Wei H
Front Oncol; 2020; 10():578816. PubMed ID: 33224879
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma.
Liu Q; Qi J; Li W; Tian X; Zhang J; Liu F; Lu X; Zang H; Liu C; Ma C; Yu Y; Jiang S
Cancer Cell Int; 2023 Nov; 23(1):298. PubMed ID: 38012755
[TBL] [Abstract][Full Text] [Related]
13. N6-Methyladenosine Methylation of mRNA in Cell Apoptosis.
Zhang L; Xia J
Mol Neurobiol; 2023 Dec; ():. PubMed ID: 38040996
[TBL] [Abstract][Full Text] [Related]
14. β-hydroxybutyrate inhibits malignant phenotypes of prostate cancer cells through β-hydroxybutyrylation of indoleacetamide-N-methyltransferase.
Zhang Y; Li Y
Cancer Cell Int; 2024 Mar; 24(1):121. PubMed ID: 38555451
[TBL] [Abstract][Full Text] [Related]
15. METTL3 alters capping enzyme expression and its activity on ribosomal proteins.
Del Valle-Morales D; Romano G; Le P; Saviana M; Brown R; Micalo L; Li H; La Ferlita A; Nigita G; Nana-Sinkam P; Acunzo M
bioRxiv; 2023 Nov; ():. PubMed ID: 38045284
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of METTL3 Alleviates NLRP3 Inflammasome Activation via Increasing Ubiquitination of NEK7.
Zhou X; Yang X; Huang S; Lin G; Lei K; Wang Q; Lin W; Li H; Qi X; Seriwatanachai D; Yang S; Shao B; Yuan Q
Adv Sci (Weinh); 2024 May; ():e2308786. PubMed ID: 38696610
[TBL] [Abstract][Full Text] [Related]
17. METTL3 exacerbates insulin resistance in hepatocytes by regulating m
Li Y; Zhang D; Gao Y; Wang P; Wang Z; Zhang B; Liu J; Ye D; Ma W; Lu S
Nutr Metab (Lond); 2023 Sep; 20(1):40. PubMed ID: 37710320
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the effects of METTL3 on alternative splicing in prostate cancer.
Wang L; Shi L; Liang Y; Ng JK; Yin CH; Wang L; Hou J; Wang Y; Fung CS; Chiu PK; Ng CF; Tsui SK
Front Oncol; 2023; 13():1227016. PubMed ID: 37675218
[TBL] [Abstract][Full Text] [Related]
19. METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients.
Tan Q; Yang L; Yuan S; Zheng D; Lin Y; Chen K; He Y; Chen S; Hao J; Dai J; He S; Mao F; Leng X; Jiang H; Yang J
Open Med (Wars); 2024; 19(1):20240899. PubMed ID: 38463525
[TBL] [Abstract][Full Text] [Related]
20. The mRNA methyltransferase Mettl3 modulates cytokine mRNA stability and limits functional responses in mast cells.
Leoni C; Bataclan M; Ito-Kureha T; Heissmeyer V; Monticelli S
Nat Commun; 2023 Jun; 14(1):3862. PubMed ID: 37386028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
